Bradley Allen Kreger - May 20, 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
SVP, Global Operations
Signature
/s/ Bradley Kreger by Nicholas Khadder, Attorney-in-Fact
Stock symbol
LAB
Transactions as of
May 20, 2022
Transactions value $
-$29,584
Form type
4
Date filed
5/23/2022, 08:16 PM
Previous filing
Feb 24, 2022
Next filing
Dec 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock Options Exercise $0 +3.13 K +3.42% $0.00 94.4 K May 20, 2022 Direct
transaction LAB Common Stock Options Exercise $0 +2.24 K +2.37% $0.00 96.7 K May 20, 2022 Direct
transaction LAB Common Stock Options Exercise $0 +2.39 K +2.47% $0.00 99.1 K May 20, 2022 Direct
transaction LAB Common Stock Options Exercise $0 +25 K +25.24% $0.00 124 K May 20, 2022 Direct
transaction LAB Common Stock Options Exercise $0 +9.53 K +7.68% $0.00 134 K May 20, 2022 Direct
transaction LAB Common Stock Tax liability -$29.6 K -14.4 K -10.8% $2.05 119 K May 20, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Restricted Stock Units Options Exercise $0 -3.13 K -100% $0.00 0 May 20, 2022 Common Stock 3.13 K Direct F1, F2
transaction LAB Restricted Stock Units Options Exercise $0 -2.24 K -25% $0.00 6.71 K May 20, 2022 Common Stock 2.24 K Direct F1, F3
transaction LAB Restricted Stock Units Options Exercise $0 -2.39 K -12.5% $0.00 16.7 K May 20, 2022 Common Stock 2.39 K Direct F1, F4
transaction LAB Restricted Stock Units Options Exercise $0 -25 K -50% $0.00 25 K May 20, 2022 Common Stock 25 K Direct F1, F5
transaction LAB Restricted Stock Units Options Exercise $0 -9.53 K -25% $0.00 28.6 K May 20, 2022 Common Stock 9.53 K Direct F1, F6

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F2 On April 30, 2018, the Reporting Person was granted 50,000 Restricted Stock Units vesting as to 1/4th of the total number of shares on May 20, 2019, and as to 1/16th of the total number of shares each quarter thereafter.
F3 On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.
F4 On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.
F5 On May 23, 2020, the Reporting Person was granted 100,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023.
F6 On April 20, 2021, the Reporting Person was granted 38,111 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.